Cardiology

New discoveries in lupus research

Two separate findings by a University of Houston nationally recognized expert in systemic lupus erythematosus (SLE or lupus), a chronic autoimmune disease that affects multiple organs including the kidneys, skin, joints and ...

Diseases, Conditions, Syndromes

Advancing diagnostics for lupus nephritis

The nature of a typical clinical test for lupus nephritis (LN), an inflammation of the kidneys and a leading cause of mortality in lupus patients, is fraught with difficulty. The invasive renal biopsy can be painful and may ...

Medications

ACR updates guidelines for peri-TJA med use in rheumatic disease

In a guideline summary issued by the American College of Rheumatology (ACR) and the American Association of Hip and Knee Surgeons (AAHKS), updated recommendations are presented for the use of medications among patients with ...

Medications

Dose range for iberdomide studied in systemic lupus erythematosus

For patients with systemic lupus erythematosus (SLE), iberdomide at a higher dose is superior to placebo for the rate of response indicating reduction in disease activity, according to a study published in the March 17 issue ...

Diseases, Conditions, Syndromes

Belimumab promising in combination therapy for refractory lupus

For patients with systemic lupus erythematosus (SLE) refractory to conventional treatment, belimumab after rituximab significantly reduces serum immunoglobulin (Ig)G anti-double stranded DNA (dsDNA) levels and the risk for ...

Diseases, Conditions, Syndromes

Mortality highest for Asians, Hispanic/Latinos with lupus

(HealthDay)—Standardized mortality ratios (SMRs) of observed-to-expected deaths are increased for patients with systemic lupus erythematosus (SLE) and are especially high for Asians and Hispanic/Latinos, according to research ...

page 2 from 11